Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Amgen’s Stelara biosimilar gets off to fast start
BioPharma Dive
Sun, 05/4/25 - 12:00 pm
Amgen
Stelara
biosimilars
JNJ
Samsung Bioepis releases Q2 2025 Biosimilar Market report
Drug Store News
Fri, 04/25/25 - 11:12 am
Samsung Bioepis
biosimilars
Stelara
Tariffs 'could cancel out discounts with biosimilars'
Pharmaphorum
Thu, 04/17/25 - 11:06 am
biosimilars
Biosimilars Forum
tariffs
Jobevne (Bevacizumab) Gains FDA Nod, Biocon Expands US Oncology Biosimilars Portfolio
Xtalks
Sun, 04/13/25 - 11:15 pm
Jobevne
bevacizumab-nwgd
Biocon Biologics
biosimilars
Avastin
cancer
FDA
J&J takes Samsung Bioepis to court over claims Korean company breached Stelara biosim settlement
Fierce Pharma
Tue, 02/25/25 - 11:00 am
JNJ
Samsung Bioepis
Korea
legal
Stelara
biosimilars
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
MSN/Reuters
Fri, 02/21/25 - 11:18 am
Teva Pharmaceutical
Alvotech
biosimilars
Stelara
autoimmune disease
Selarsdi
Crohn's Disease
ulcerative colitis
plaque psoriasis
First biosimilar fast-acting insulin reaches US market
Pharmaphorum
Tue, 02/18/25 - 09:47 am
Sanofi
Novo Nordisk
Novolog
insulin
diabetes
biosimilars
Merilog
With recent launches and more to come, Amgen's biosimilar business is trending up
Fierce Pharma
Thu, 02/6/25 - 11:43 am
Amgen
biosimilars
Regeneron patents block biosimilar entry for Eylea
Patently-O
Thu, 01/30/25 - 11:26 pm
Regeneron
Eylea
legal
biosimilars
patents
Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June
Fierce Pharma
Wed, 01/29/25 - 11:20 am
Sandoz
Amgen
Celltrion
patents
biosimilars
Prolia
Xgeva
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Wed, 01/22/25 - 11:17 am
PBMs
formularies
Caremark
Express Scripts
OptumRx
Humira
Stelara
biosimilars
Coherus, sharpening immuno-oncology focus, sells another biosimilar for over $500M
BioPharma Dive
Wed, 12/4/24 - 10:59 am
Coherus Biosciences
immuno-oncology
biosimilars
Amgen
Neulasta
Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition
Forbes
Sun, 11/10/24 - 09:31 pm
PBMs
drug rebates
biosimilars
Biosimilars Are Making Inroads In U.S., But It’s Still A Bumpy Ride
Forbes
Mon, 11/4/24 - 07:04 pm
biosimilars
Regeneron loses bid to block Amgen's Eylea biosimilar launch in US
Reuters
Tue, 10/22/24 - 11:30 pm
Regeneron
Amgen
biosimilars
Eylea
Inflation Reduction Act proves positive boost for biosimilars
Pharmaphorum
Thu, 10/10/24 - 09:49 am
Inflation Reduction Act
drug pricing
biosimilars
Teva and mAbxience partner to develop biosimilar candidate for oncology
Pharmaceutical Technology
Fri, 10/4/24 - 09:28 am
Teva Pharmaceutical
mAbxience
oncology
biosimilars
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Fierce Pharma
Tue, 09/24/24 - 11:56 am
Regeneron
Amgen
legal
biosimilars
Eylea
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
AOL
Tue, 09/10/24 - 04:33 pm
AbbVie
Humira
biosimilars
Unitedhealth Group
OptumRx
Evernorth Will Offer a Private-Label Stelara Biosimilar in 2025
Managed Healthcare Executive
Thu, 09/5/24 - 10:32 pm
Evernorth Health
Stelara
biosimilars
Janssen
JNJ
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »